Ya Deng

Ya Deng

Auto-generated profile, based on publicly available information

Ya Deng

Department of Endoscopy and Digestive System Guizhou Provincial People's Hospital Guiyang Guizhou China

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 April 2024 in Organic Letters
Verified
Journal Article
Closed access
MZMing-Zhong Zhang
Ming-Zhong Zhang
XYXin Yang
Xin Yang
JYJin-Xing Yin
Jin-Xing Yin
YDYa Deng
Ya Deng
HTHong-Ying Tan
Hong-Ying Tan
TCTieqiao Chen
Tieqiao Chen

19 February 2025 in Journal of Cellular and Molecular Medicine
Verified
Journal Article
Open access
YDYa Deng
Ya Deng
XYXiaolu Yuan
Xiaolu Yuan
XLXianMin Lu
XianMin Lu
JWJiangbo Wu
Jiangbo Wu
CLChen Luo
Chen Luo
RXRui Xie
Rui Xie
The intestinal flora has attracted much attention in recent years. An imbalance in the intestinal flora can cause not only intestinal diseases but also cause a variety of parenteral diseases, such as endocrine diseases, nervous system diseases and cardiovascular diseases. Research on the mechanism of disease is likely to be hampered by sample accessibility, ethical issues, and differences between cellular animal and physiological studies. However, advances in stem cell culture have made it possible to reproduce 3D human tissues in vitro that mimic the cellular, anatomical and functional characteristics of real organs. Recent studies have shown that organoids can be used to simulate the development and disease of the gut and intestinal flora and have a wide range of applications in intestinal flora physiology and disease. Intestinal organoids provide a preeminent in vitro model system for cultivating microbiota that influence GI physiology, as well as for understanding how they encounter intestinal epithelial cells and cause disease. The mechanistic details obtained from such modelling may provide new avenues for the prevention and treatment of many gastrointestinal (GI) disorders. Researchers are now starting to take inspiration from other fields, such as bioengineering, and the rise of interdisciplinary approaches, including organoid chip technology and microfluidics, has greatly accelerated the development of organoids to generate intestinal organoids that are more physiologically relevant and suitable for gut microbiota studies. Here, we describe the development of organoid models of gut biology and the application of organoids to study the pathophysiology of diseases caused by intestinal dysbiosis.